Literature DB >> 7559096

Point mutations of ras and Gs alpha subunit genes in thyroid tumors.

H Horie1, Y Yokogoshi, M Tsuyuguchi, S Saito.   

Abstract

We studied 43 thyroid tumors including 5 adenomatous goiters, 7 follicular adenomas, 22 papillary carcinomas, and 9 medullary carcinomas with regard to the presence of point mutations in the genes of Gs alpha subunit (Gs alpha), Gi2 alpha subunit (Gi2 alpha), H-ras, K-ras, and N-ras by a polymerase chain reaction-direct sequencing method. An adenomatous goiter and a follicular adenoma showed double mutations at codon 227 and 231, and 4 papillary carcinomas showed mutation at codon 231 of the Gs alpha gene. An adenomatous goiter, a follicular adenoma, and a papillary carcinoma showed a missense mutation in codon 13 of the K-ras gene. There were no such missense mutations of these G-protein or ras genes in medullary carcinomas. These data indicate that the genetic events involved in the oncogenesis of parafollicular C-cells are different from those of thyroid follicular cells, in which missense mutations of Gs alpha and ras genes seem to play important roles in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559096      PMCID: PMC5920910          DOI: 10.1111/j.1349-7006.1995.tb02462.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  39 in total

1.  Hyperthyroidism and thyroid cancer.

Authors:  C J Edmonds; M Tellez
Journal:  Clin Endocrinol (Oxf)       Date:  1988-02       Impact factor: 3.478

2.  Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits.

Authors:  P Crespo; N Xu; W F Simonds; J S Gutkind
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

Review 3.  Signal transduction via the MAP kinases: proceed at your own RSK.

Authors:  J Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

4.  Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

Authors:  M Santoro; F Carlomagno; I D Hay; M A Herrmann; M Grieco; R Melillo; M A Pierotti; I Bongarzone; G Della Porta; N Berger
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

5.  C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.

Authors:  K P Yang; S G Castillo; C V Nguyen; R C Hickey; N A Samaan
Journal:  Anticancer Res       Date:  1990 Jan-Feb       Impact factor: 2.480

6.  Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.

Authors:  M A Herrmann; I D Hay; D H Bartelt; S R Ritland; R J Dahl; C S Grant; R B Jenkins
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

7.  The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area.

Authors:  A Belfiore; G L La Rosa; G Padova; L Sava; O Ippolito; R Vigneri
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

8.  Activating point mutations of the gsp oncogene in human thyroid adenomas.

Authors:  C O'Sullivan; C M Barton; S L Staddon; C L Brown; N R Lemoine
Journal:  Mol Carcinog       Date:  1991       Impact factor: 4.784

9.  Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature.

Authors:  M Uribe; C M Fenoglio-Preiser; M Grimes; C Feind
Journal:  Am J Surg Pathol       Date:  1985-08       Impact factor: 6.394

10.  Inactivation of the p53 gene is not required for tumorigenesis of medullary thyroid carcinoma or pheochromocytoma.

Authors:  I Yana; T Nakamura; E Shin; K Karakawa; H Kurahashi; Y Kurita; T Kobayashi; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1992-11
View more
  6 in total

Review 1.  Molecular insights into TSH receptor abnormality and thyroid disease.

Authors:  D Russo; F Arturi; E Chiefari; S Filetti
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

2.  Non-hyperfunctioning nodules from multinodular goiters: a minor role in pathogenesis for somatic activating mutations in the TSH-receptor and Gsalpha subunit genes.

Authors:  C Derrien; E Sonnet; I Gicquel; J Y Le Gall; J Y Poirier; V David; D Maugendre
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

Review 3.  Thyroid C-Cell Biology and Oncogenic Transformation.

Authors:  Gilbert J Cote; Elizabeth G Grubbs; Marie-Claude Hofmann
Journal:  Recent Results Cancer Res       Date:  2015

4.  Thyroid follicular oncogenesis in iodine-deficient and iodine-sufficient areas: search for alterations of the ras, met and bFGF oncogenes and of the Rb anti-oncogene.

Authors:  L Bartolone; F Vermiglio; M D Finocchiaro; M A Violi; D French; A Pontecorvi; F Trimarchi; S Benvenga
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

5.  Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon.

Authors:  A Boichard; L Croux; A Al Ghuzlan; S Broutin; C Dupuy; S Leboulleux; M Schlumberger; J M Bidart; L Lacroix
Journal:  J Clin Endocrinol Metab       Date:  2012-08-03       Impact factor: 5.958

Review 6.  The Genomic Landscape of Thyroid Cancer Tumourigenesis and Implications for Immunotherapy.

Authors:  Amandeep Singh; Jeehoon Ham; Joseph William Po; Navin Niles; Tara Roberts; Cheok Soon Lee
Journal:  Cells       Date:  2021-05-01       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.